Login

4D Pharma hopes to expand drug success to other areas - Duncan Peyton, CEO, 4D Pharma 00:00:00

Share On Facebook Share On Twitter

4D Pharma hopes to expand drug success to other areas

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Dawn E. Jaroszewski, M.D. Cardiothoracic Surgeon, Mayo Clinic
00:10:00
We take an operators approach to investing|Gareth Jones, Managing Partner,FinTech Collective
00:00:00
Wesley Wong Associate Professor of Biological Chemistry and Molecular Pharmacology, HMS
00:10:00
Yukikazu Myochin, CEO of "K" LINE, Named in CDP2022 'A List' Companies | Yukikazu Myochin - CEO of kawasaki kisen kaisha ltd
00:10:00
Emcore COO Speaks to Media | Jeffrey Rittichier, CEO, EMCORE CorpEMKR:NMQ
00:10:00
Canada Culvert's Cost-Effective Infrastructure Rehabilitation Solutions
00:10:00
From Tinkering with Appliances to Transforming Clinical Trials|Ryan Jones,CEO,Florence Healthcare
00:10:00
Fusion: Reviving Liberty and Tradition in American Political Thought|Samuel Goldman,Professor,George Washington University
00:10:00
Urgent Call for Action: Confronting Systemic Racism in Canada | Gary Anandasangaree, Minister of crown-indigenous relations and northern affairs canada
00:10:00
Rafaela Resources: Developing Critical Metals Projects in Spain and Canada
00:10:00
Navigating Alternative Lending: Insights from Blake Albright | Founder and Managing Director at Brightpath Capital
00:10:00
Navigating Raw Material Challenges: Tire Industry Demand and Growth Outlook for 2023|Mr. Suresh Sodani,Managing Director,Century Enka Ltd

© 2017 - Neuhu+